Chemotherapy in Psychiatry: Pharmacologic Basis of Treatments for Major Mental Illness
Autor Ross J. Baldessarinien Limba Engleză Paperback – 11 iun 2013
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 760.90 lei 6-8 săpt. | |
Springer – 11 iun 2013 | 760.90 lei 6-8 săpt. | |
Hardback (1) | 1078.35 lei 6-8 săpt. | |
Springer – 28 sep 2012 | 1078.35 lei 6-8 săpt. |
Preț: 760.90 lei
Preț vechi: 800.95 lei
-5% Nou
Puncte Express: 1141
Preț estimativ în valută:
145.67€ • 151.41$ • 120.77£
145.67€ • 151.41$ • 120.77£
Carte tipărită la comandă
Livrare economică 06-20 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461479260
ISBN-10: 1461479266
Pagini: 272
Ilustrații: XI, 272 p. 36 illus.
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.36 kg
Ediția:3rd ed. 2013
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
ISBN-10: 1461479266
Pagini: 272
Ilustrații: XI, 272 p. 36 illus.
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.36 kg
Ediția:3rd ed. 2013
Editura: Springer
Colecția Springer
Locul publicării:New York, NY, United States
Public țintă
Professional/practitionerCuprins
Modern Psychopharmacology and Psychiatric Treatment.- Antipsychotic Agents.- Antimanic and Mood-stabilizing Agents.- Antidepressant Agents.- Antianxiety Agents.- Status and Prospects for Psychopharmacology.Bibliography.- Index.
Recenzii
From the reviews of the third edition:
“This is an update of a book that strives to educate readers about the proper research-driven uses and limitations of psychiatric medications as one part of a multifactorial treatment approach for psychiatric patients. … practitioners who prescribe psychiatric medications would get the most benefit, particularly those who are in residency training. … This is one of the best books I have read on this subject. … The text is very readable, making it appropriate for new psychiatrists as well as helpful for seasoned psychiatrists.” (Aaron Plattner, Doody’s Review Service, February, 2013)
“This is an update of a book that strives to educate readers about the proper research-driven uses and limitations of psychiatric medications as one part of a multifactorial treatment approach for psychiatric patients. … practitioners who prescribe psychiatric medications would get the most benefit, particularly those who are in residency training. … This is one of the best books I have read on this subject. … The text is very readable, making it appropriate for new psychiatrists as well as helpful for seasoned psychiatrists.” (Aaron Plattner, Doody’s Review Service, February, 2013)
Textul de pe ultima copertă
Extensively updated since its second edition in 1985, Chemotherapy in Psychiatry, Third Edition, again addresses basic aspects of modern psychopharmacology and clinical applications of drugs used in the treatment of major psychiatric disorders, with major emphasis on psychotic, bipolar, and depressive disorders. The presentation covers descriptions of the main classes of psychotropic drugs, selected information concerning their known action mechanisms and metabolic disposition, and their clinical applications for acute illnesses and to prevent recurrences and long-term morbidity. Also covered are limitations and adverse effects of each type of agent, with emphasis on the fact that all psychotropic medicines have adverse effects that range from annoying to potentially lethal. Chemotherapy in Psychiatry, Third Edition, outlines the need to balance benefits and risks at the level of individual persons. Authoritative, and an important contribution to the literature, Chemotherapy in Psychiatry, Third Edition is an invaluable resource for physicians, scientists, trainees, and policymakers.
Caracteristici
Third edition of highly successful title authored by a renowned leader in the field Provides the most up-to-date evidence regarding the chemistry, metabolism, mechanism of action, dosing, and adverse effects of psychopharmacologic agents Offers in depth discussion, including controversial issues, involving the major classes of psychopharmacologic drugs